These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 18822216)

  • 1. [The effects of glycine on the expression of peroxisome-proliferator-activated receptor gamma in nonalcoholic fatty rat livers].
    Liu JC; Guo YR; Chai B
    Zhonghua Gan Zang Bing Za Zhi; 2008 Sep; 16(9):702-3. PubMed ID: 18822216
    [No Abstract]   [Full Text] [Related]  

  • 2. Peroxisome proliferator-activated receptor-alpha and -gamma mRNA levels are reduced in chronic hepatitis C with steatosis and genotype 3 infection.
    de Gottardi A; Pazienza V; Pugnale P; Bruttin F; Rubbia-Brandt L; Juge-Aubry CE; Meier CA; Hadengue A; Negro F
    Aliment Pharmacol Ther; 2006 Jan; 23(1):107-14. PubMed ID: 16393287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retinol-binding protein 4 and peroxisome proliferator-activated receptor-γ in steatotic liver transplantation.
    Casillas-Ramírez A; Alfany-Fernández I; Massip-Salcedo M; Juan ME; Planas JM; Serafín A; Pallàs M; Rimola A; Rodés J; Peralta C
    J Pharmacol Exp Ther; 2011 Jul; 338(1):143-53. PubMed ID: 21487070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced expression of peroxisome proliferator-activated receptor-alpha may have an important role in the development of non-alcoholic fatty liver disease.
    Yeon JE; Choi KM; Baik SH; Kim KO; Lim HJ; Park KH; Kim JY; Park JJ; Kim JS; Bak YT; Byun KS; Lee CH
    J Gastroenterol Hepatol; 2004 Jul; 19(7):799-804. PubMed ID: 15209628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PPAR agonists treatment is effective in a nonalcoholic fatty liver disease animal model by modulating fatty-acid metabolic enzymes.
    Seo YS; Kim JH; Jo NY; Choi KM; Baik SH; Park JJ; Kim JS; Byun KS; Bak YT; Lee CH; Kim A; Yeon JE
    J Gastroenterol Hepatol; 2008 Jan; 23(1):102-9. PubMed ID: 18171348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The expression of PPAR gamma in experimental fatty liver disease].
    Zhao YC; Jiang LL; Li JM; Liang BL; Li L
    Zhonghua Gan Zang Bing Za Zhi; 2004 Jul; 12(7):437. PubMed ID: 15268815
    [No Abstract]   [Full Text] [Related]  

  • 7. Therapy for nonalcoholic fatty liver disease.
    Moseley RH
    J Clin Gastroenterol; 2008 Apr; 42(4):332-5. PubMed ID: 18277910
    [No Abstract]   [Full Text] [Related]  

  • 8. Differential effects of in vivo PPAR alpha and gamma activation on fatty acid transport proteins expression and lipid content in rat liver.
    Wierzbicki M; Chabowski A; Zendzian-Piotrowska M; Gorski J
    J Physiol Pharmacol; 2009 Mar; 60(1):99-106. PubMed ID: 19439812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Role of peroxisome proliferator activated receptor alpha in the pathogenesis of nonalcoholic steatohepatitis].
    Zhao CY; Deng ZJ; Zhou JY
    Zhonghua Gan Zang Bing Za Zhi; 2006 Feb; 14(2):146-7. PubMed ID: 16494792
    [No Abstract]   [Full Text] [Related]  

  • 10. Divergent effects of peroxisome proliferator-activated receptor-gamma ligands in human and mouse nonalcoholic steatohepatitis.
    Caldwell SH; Argo CK
    Hepatology; 2007 Aug; 46(2):285-7. PubMed ID: 17661403
    [No Abstract]   [Full Text] [Related]  

  • 11. Long-term exercise increases the DNA binding activity of peroxisome proliferator-activated receptor gamma in rat adipose tissue.
    Petridou A; Tsalouhidou S; Tsalis G; Schulz T; Michna H; Mougios V
    Metabolism; 2007 Aug; 56(8):1029-36. PubMed ID: 17618946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diverse regulation of NF-kappaB and peroxisome proliferator-activated receptors in murine nonalcoholic fatty liver.
    Romics L; Kodys K; Dolganiuc A; Graham L; Velayudham A; Mandrekar P; Szabo G
    Hepatology; 2004 Aug; 40(2):376-85. PubMed ID: 15368442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The expression and significance of osteopontin in the development of nonalcoholic fatty liver fibrosis in rats].
    Liu P; Chen DF; Wang J; Ai ZL; Fan LL; Wang XM; Yan LL
    Zhonghua Gan Zang Bing Za Zhi; 2008 Nov; 16(11):831-4. PubMed ID: 19032867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Relationship between NF-kappa B binding activity and expression of PPAR gamma-mRNA in the livers of rats with fatty liver disease].
    Zhao CY; Wang JB; Deng ZJ; Liu JW; Li JM; Li L; Jiang LL
    Zhonghua Gan Zang Bing Za Zhi; 2005 Feb; 13(2):96-100. PubMed ID: 15727693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic, in vivo, PPARalpha activation prevents lipid overload in rat liver induced by high fat feeding.
    Wierzbicki M; Chabowski A; Zendzian-Piotrowska M; Harasim E; Górski J
    Adv Med Sci; 2009; 54(1):59-65. PubMed ID: 19403437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of fatty acid metabolism-related gene expression in nonalcoholic fatty liver disease.
    Nakamuta M; Kohjima M; Morizono S; Kotoh K; Yoshimoto T; Miyagi I; Enjoji M
    Int J Mol Med; 2005 Oct; 16(4):631-5. PubMed ID: 16142397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The anti-inflammatory effect of curcumin in an experimental model of sepsis is mediated by up-regulation of peroxisome proliferator-activated receptor-gamma.
    Siddiqui AM; Cui X; Wu R; Dong W; Zhou M; Hu M; Simms HH; Wang P
    Crit Care Med; 2006 Jul; 34(7):1874-82. PubMed ID: 16715036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcriptional networks in a rat model for nonalcoholic fatty liver disease: a microarray analysis.
    Sharma MR; Polavarapu R; Roseman D; Patel V; Eaton E; Kishor PB; Nanji AA
    Exp Mol Pathol; 2006 Dec; 81(3):202-10. PubMed ID: 16949573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention/reversal of choline deficiency-induced steatohepatitis by a peroxisome proliferator-activated receptor alpha ligand in rats.
    Rao MS; Papreddy K; Musunuri S; Okonkwo A
    In Vivo; 2002; 16(2):145-52. PubMed ID: 12073774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of peroxisome proliferator-activated receptor-gamma in liver fibrosis.
    Yang L; Chan CC; Kwon OS; Liu S; McGhee J; Stimpson SA; Chen LZ; Harrington WW; Symonds WT; Rockey DC
    Am J Physiol Gastrointest Liver Physiol; 2006 Nov; 291(5):G902-11. PubMed ID: 16798724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.